Analysen von Chris Eccles

14.12.12 Hikma Pharmaceuticals overweight Morgan Stanley
19.11.12 Sanofi overweight Morgan Stanley
12.11.12 Novo Nordisk equal-weight Morgan Stanley
09.11.12 Sanofi overweight Morgan Stanley
26.10.12 Sanofi overweight Morgan Stanley
26.10.12 Novo Nordisk equal-weight Morgan Stanley
10.10.12 Sanofi overweight Morgan Stanley
04.10.12 Shire overweight Morgan Stanley
27.09.12 UCB overweight Morgan Stanley
26.09.12 AstraZeneca overweight Morgan Stanley
20.09.12 Shire overweight Morgan Stanley
17.09.12 UCB overweight Morgan Stanley